572 related articles for article (PubMed ID: 9132006)
1. Taxol differentially modulates the dynamics of microtubules assembled from unfractionated and purified beta-tubulin isotypes.
Derry WB; Wilson L; Khan IA; Luduena RF; Jordan MA
Biochemistry; 1997 Mar; 36(12):3554-62. PubMed ID: 9132006
[TBL] [Abstract][Full Text] [Related]
2. Low potency of taxol at microtubule minus ends: implications for its antimitotic and therapeutic mechanism.
Derry WB; Wilson L; Jordan MA
Cancer Res; 1998 Mar; 58(6):1177-84. PubMed ID: 9515803
[TBL] [Abstract][Full Text] [Related]
3. The microtubule-stabilizing agent discodermolide competitively inhibits the binding of paclitaxel (Taxol) to tubulin polymers, enhances tubulin nucleation reactions more potently than paclitaxel, and inhibits the growth of paclitaxel-resistant cells.
Kowalski RJ; Giannakakou P; Gunasekera SP; Longley RE; Day BW; Hamel E
Mol Pharmacol; 1997 Oct; 52(4):613-22. PubMed ID: 9380024
[TBL] [Abstract][Full Text] [Related]
4. Characterization of nuclear betaII-tubulin in tumor cells: a possible novel target for taxol.
Xu K; Ludueña RF
Cell Motil Cytoskeleton; 2002 Sep; 53(1):39-52. PubMed ID: 12211114
[TBL] [Abstract][Full Text] [Related]
5. Substoichiometric binding of taxol suppresses microtubule dynamics.
Derry WB; Wilson L; Jordan MA
Biochemistry; 1995 Feb; 34(7):2203-11. PubMed ID: 7857932
[TBL] [Abstract][Full Text] [Related]
6. Effect of alkaline pH on taxol-microtubule interactions.
Ringel I; Horwitz SB
J Pharmacol Exp Ther; 1991 Nov; 259(2):855-60. PubMed ID: 1682488
[TBL] [Abstract][Full Text] [Related]
7. Dicoumarol: a unique microtubule stabilizing natural product that is synergistic with Taxol.
Madari H; Panda D; Wilson L; Jacobs RS
Cancer Res; 2003 Mar; 63(6):1214-20. PubMed ID: 12649179
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of natural product microtubule stabilizers on microtubule assembly: single agent and combination studies with taxol, epothilone B, and discodermolide.
Gertsch J; Meier S; Müller M; Altmann KH
Chembiochem; 2009 Jan; 10(1):166-75. PubMed ID: 19058273
[TBL] [Abstract][Full Text] [Related]
9. Elongation factor-1alpha stabilizes microtubules in a calcium/calmodulin-dependent manner.
Moore RC; Durso NA; Cyr RJ
Cell Motil Cytoskeleton; 1998; 41(2):168-80. PubMed ID: 9786091
[TBL] [Abstract][Full Text] [Related]
10. Identification of a novel taxol-sensitive kinase activity associated with the cytoskeleton.
Wang Y; Duncan R; Ann DK; Hamm-Alvarez SF
Biochem Biophys Res Commun; 2000 Nov; 277(3):525-30. PubMed ID: 11061987
[TBL] [Abstract][Full Text] [Related]
11. Mechanism of action of the unusually potent microtubule inhibitor cryptophycin 1.
Panda D; Himes RH; Moore RE; Wilson L; Jordan MA
Biochemistry; 1997 Oct; 36(42):12948-53. PubMed ID: 9335554
[TBL] [Abstract][Full Text] [Related]
12. Modulation of endogenous beta-tubulin isotype expression as a result of human beta(III)cDNA transfection into prostate carcinoma cells.
Ranganathan S; McCauley RA; Dexter DW; Hudes GR
Br J Cancer; 2001 Sep; 85(5):735-40. PubMed ID: 11531260
[TBL] [Abstract][Full Text] [Related]
13. Removal of beta III isotype enhances taxol induced microtubule assembly.
Lu Q; Luduena RF
Cell Struct Funct; 1993 Jun; 18(3):173-82. PubMed ID: 7902216
[TBL] [Abstract][Full Text] [Related]
14. Suppression of microtubule dynamics by binding of cemadotin to tubulin: possible mechanism for its antitumor action.
Jordan MA; Walker D; de Arruda M; Barlozzari T; Panda D
Biochemistry; 1998 Dec; 37(50):17571-8. PubMed ID: 9860873
[TBL] [Abstract][Full Text] [Related]
15. Fluorescent taxoids as probes of the microtubule cytoskeleton.
Evangelio JA; Abal M; Barasoain I; Souto AA; Lillo MP; Acuña AU; Amat-Guerri F; Andreu JM
Cell Motil Cytoskeleton; 1998; 39(1):73-90. PubMed ID: 9453715
[TBL] [Abstract][Full Text] [Related]
16. Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells.
Banerjee A
Biochem Biophys Res Commun; 2002 Apr; 293(1):598-601. PubMed ID: 12054644
[TBL] [Abstract][Full Text] [Related]
17. Suppression of centromere dynamics by Taxol in living osteosarcoma cells.
Kelling J; Sullivan K; Wilson L; Jordan MA
Cancer Res; 2003 Jun; 63(11):2794-801. PubMed ID: 12782584
[TBL] [Abstract][Full Text] [Related]
18. Expression of beta-tubulin isotypes in human ovarian carcinoma xenografts and in a sub-panel of human cancer cell lines from the NCI-Anticancer Drug Screen: correlation with sensitivity to microtubule active agents.
Nicoletti MI; Valoti G; Giannakakou P; Zhan Z; Kim JH; Lucchini V; Landoni F; Mayo JG; Giavazzi R; Fojo T
Clin Cancer Res; 2001 Sep; 7(9):2912-22. PubMed ID: 11555610
[TBL] [Abstract][Full Text] [Related]
19. Discodermolide, a cytotoxic marine agent that stabilizes microtubules more potently than taxol.
ter Haar E; Kowalski RJ; Hamel E; Lin CM; Longley RE; Gunasekera SP; Rosenkranz HS; Day BW
Biochemistry; 1996 Jan; 35(1):243-50. PubMed ID: 8555181
[TBL] [Abstract][Full Text] [Related]
20. Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition.
Díaz JF; Andreu JM
Biochemistry; 1993 Mar; 32(11):2747-55. PubMed ID: 8096151
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
